Maternal deaths following nevirapine-based antiretroviral therapy
We report 2 cases illustrating that it is too simplistic to link nevirapine (NVP) toxicity exclusively to individuals with immune preservation. Not enough is known about the mechanism of hepatotoxicity or cutaneous eruption to predict these events. This type of hypersensitivity reaction occurs rarel...
Saved in:
Main Authors: | E Bera (Author), D Naidoo (Author), M Williams (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2012-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report
by: Yamazhan Tansu, et al.
Published: (2002) -
Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon
by: Gwet Henri, et al.
Published: (2010) -
Cytotoxicity, genotoxicity, and mutagenicity of the active pharmaceutical ingredient nevirapine and a nevirapine-based drug on the plant species Allium cepa
by: Juliana Souki Diniz, et al.
Published: (2023) -
FDA Public Advisory for Nevirapine (Viramune)
by: Editorial Office
Published: (2005) -
Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals
by: Prabhakar Panzade, et al.
Published: (2021)